Your browser doesn't support javascript.
loading
Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response"by Bonelli et al.
Benucci, Maurizio; Damiani, Arianna; Infantino, Maria; Manfredi, Mariangela; Grossi, Valentina; Lari, Barbara; Li Gobbi, Francesca; Sarzi Puttini, Piercarlo.
Afiliação
  • Benucci M; Rheumatology Unit, San Giovanni di Dio Hospital, Azienda USL Toscana Centro, Firenze, Italy maubenucci@tiscali.it.
  • Damiani A; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Florence, Firenze, Italy.
  • Infantino M; Immunology and Allergology Laboratory, San Giovanni di Dio Hospital, Florence, Italy.
  • Manfredi M; Immunology and Allergology Laboratory, San Giovanni di Dio Hospital, Florence, Italy.
  • Grossi V; Immunology and Allergology Laboratory, San Giovanni di Dio Hospital, Florence, Italy.
  • Lari B; Immunology and Allergology Laboratory, San Giovanni di Dio Hospital, Florence, Italy.
  • Li Gobbi F; Rheumatology Unit, San Giovanni di Dio Hospital, Firenze, Italy.
  • Sarzi Puttini P; Rheumatology Unit, ASST-Fatebenefratelli L. Sacco University Hospital, University of Milan, Milan, Italy.
Ann Rheum Dis ; 80(10): e166, 2021 10.
Article em En | MEDLINE | ID: mdl-34340979

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article